International Patent: CANCER TREATMENTS USING MTA-COOPERATIVE PRMT5 INHIBITORS

GENEVA, Sept. 24 -- AMGEN INC. filed a patent application (US2025/021444) for “CANCER TREATMENTS USING MTA-COOPERATIVE PRMT5 INHIBITORS”. With publication no. WO/2025/207705, here are the other details related to the patent application:

Kind: Correction of entry in Section I of the PCT Gazette [A8]

IPC: A61K 31/337

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....